Encouraging economic data and corporate-earnings reports lifted US equity markets to new highs in November. Following 4.6% growth in the second quarter, US third quarter GDP growth was revised upwards 40 basis points to 3.9% due to strong consumer spending. However, weaker-than-expected capital-goods orders and a spike in US jobless claims, coupled with slow manufacturing […]
St. Louis, MO 11/3/14; Washington, DC 11/3/14; Washington, DC 11/25/14—Sigma-Aldrich has announced that it will hold a special stockholder meeting on December 5 to vote on Merck KGaA’s proposed acquisition of the company (see IBO 9/30/14). In addition, Sigma announced an agreement to settle one of three putative class-action suits brought by shareholders against the […]
Oberkochen, Germany 11/13/14—ZEISS has announced that it plans to reduce costs in its Microscopy business, according to a Google translation of a German press release from the company. The aim is to save at least $100 million in the medium term and to increase profitability and competitiveness. Three-quarters of the savings will come from fixed […]
Waltham, MA 11/24/14; Stockholm, Sweden 11/24/14—PerkinElmer has agreed to acquire Perten Instruments from Valedo Partners Fund, the Perten family and key staff of Perten for $266 million. Perten develops and markets instruments, a food-quality-calibration database and ancillary services for advanced QC of food, grain, flour and feed. Based in Stockholm, Sweden, Perten has annual revenues […]
Santa Clara, CA 11/3/14; Santa Clara, 11/20/14—Agilent Technologies has announced that beginning with the current quarter, the first quarter of its fiscal year 2015, it will report in three new divisions: the Life Sciences and Applied Markets Group (LSAG), the Diagnostics and Genomics Group (DGG), and the Agilent CrossLab Group (see IBO 9/30/14). “The organization […]
The calendar-year third quarter produced mixed financial results for the revenues of major publicly held analytical instrument and laboratory-product businesses. Growth in selected clinical and pharmaceutical end-markets offset continued weakness in industrial end-markets and China. Companies forecast little change for the next quarter. Revenues for the seven businesses whose results are detailed on pages 9–11 […]
This month, Eurostat released the first estimates of 2013 R&D expenditures of the 28 EU member states. Also provided was a breakdown of expenditures by sector, and R&D intensity (R&D expenditure as a percentage of GDP) for each country. The report of R&D intensity is the first using the new European System of Accounts (ESA). […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
